Surgical Innovations - Board Changes
Surgical Innovations Group plc
("Surgical Innovations", the "Company", or the "Group")
Board Changes
Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces an evolution to the Board of Directors of the Company as detailed below.
The Company announces the appointments of
Simultaneously,
Roy joins the Board with a mandate to work alongside the current Executive Directors,
Roy is an experienced executive with over 35 years of global experience in a variety of industries including medtech, diagnostics and technology sectors. He is currently Chairman of Inspiration Healthcare Group plc, a leading neonatal respiratory company, and Foster & Freeman Ltd (the trading name of the Galton group of companies), a leading forensic imaging manufacturer. He is also a Non-Executive Director of Futura Medical plc, a
Before these Non-Executive roles Roy served as the Chief Executive Officer of Optos plc, a leading ophthalmology medical device business, from 2008 until
Prior to this, Roy spent almost ten years with Arthur D Little, the global management consulting company, where he was vice president and global head of its operations management business. His early career included experience in the electronics, oil, and automotive sectors. Roy holds a mechanical engineering degree from the University of Southampton and an MBA from the London Business School.
Roy will become Chair of the Nomination Committee and be a member of the Renumeration and Audit Committees, effective immediately.
Andrew brings more than 30 years' experience in both Executive and Non-Executive roles in the financial sector. Andrew is currently Non-Executive Director and Audit Committee Chair at Octopus AIM VCT plc and Non-Executive Director and Audit Committee Chair at Cake Box Holdings plc. Andrew was previously Non-Executive Director and chair of Remuneration and Audit at LungLifeAI plc. He has been on CEN Group Holdings' Advisory Panel since 2021. Previously, he was CFO at Gooch & Housego PLC (2009-2019) and Finance Director at Riverford Organic Farmers (2019-2023).
Andrew will become Chair of the Audit and Remuneration Committees and a member of the Nominations Committee, effective immediately.
Duncan has over 35 years of investment experience. Having worked in investment banking for 10 years (1984-1994), latterly with Bear Stearns as managing director in charge of the company's non-US equity business,
Duncan will be a member of the Nominations and Audit Committees, with immediate effect.
"I am delighted to join the Board of Surgical Innovations, a company I have known since my time at Gyrus Group plc. I believe that Surgical Innovation's range of innovative ReposableTM products provide an exciting platform for improving minimally invasive surgery and I am excited to be able to work with David, Brent and the new Board in looking at how we can maximize shareholder value."
"I am delighted to welcome Roy, Andrew and Duncan to the Board and look forward to working closely with them as the Company takes its next steps. I would also like to take this opportunity to thank Jon and Keyvan for their support and guidance over the past two years, which I have greatly valued and appreciated during our time working together."
For further information please contact:
|
Surgical Innovations Group plc |
|||
|
|
Tel: 0113 230 7597 |
||
|
|
|
||
|
|
|
||
|
Singer Capital Markets (Nominated Adviser & Broker) |
Tel: 020 7496 3000 |
||
|
|
|
||
|
|
|
||
|
Walbrook PR (Financial PR & Investor Relations) |
Tel: 020 7933 8780 or si@walbrookpr.com |
||
|
|
Mob: 07980 541 893 / 07584 391 303 |
||
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the
Elemental also has exclusive
In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major
We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs, the Company's Reposable portfolio enables healthcare providers to reduce both plastic waste and their CO2 footprint as they strive for net zero.

Further information
Further details of the Group's businesses and products are available on the following websites:
To receive regular updates by email, please contact si@walbrookpr.com
The following information is disclosed pursuant to Rule 17 and Schedule Two Paragraph (g) of the AIM Rules for Companies in relation to
|
Current Directorships/Partnerships |
Past Directorships/Partnership (within 5 years) |
|
· Anaesthetic Services Systems Limited · Futura Medical plc · Galton Bidco Limited · Galton Midco Limited · Galton Topco Limited · Galton Tradeco Limited · Inditherm Construction Limited · Inditherm Limited · Inditherm (Medical) Limited · Inditherm (UK) Limited · Inspiration Healthcare Group plc · Inspiration Healthcare Limited · Inspiration Homecare Limited · S.L.E. Limited · Vio Holdings Limited · Viomedex Limited
|
· Edinburgh Molecular Imaging Limited · LungLife AI, Inc. · Medica Group Limited · Rair Health Limited |
In addition to the above,
The following information is disclosed pursuant to Rule 17 and Schedule Two Paragraph (g) of the AIM Rules for Companies in relation to
|
Current Directorships/Partnerships |
Past Directorships/Partnership (within 5 years) |
|
· Cake Box Holdings plc · · Octopus AIM VCT plc
|
· Lunglife AI, Inc. · Riverford Organic Farmers Limited |
The following information is disclosed pursuant to Rule 17 and Schedule Two Paragraph (g) of the AIM Rules for Companies in relation to
|
Current Directorships/Partnerships |
Past Directorships/Partnership (within 5 years) |
|
· Acquisitor Ltd · Alfalfa Holdings AG · Alina (BVI) Ltd · Alina Holdings plc · Anemoi International Ltd · Apeiron Holdings (BVI) Ltd · Auld Mug Inns limited · Citypoint Holdings Ltd · DOA Alpha Ltd · DOA Delta Ltd · DOA Exploration Limited · Fleur-d-lys Management Ltd · ID4 AG · NOS Holdings Limited · NOS 4 Limited · NOS 5 Limited · NOS 6 Limited · Peregrine Property Company Limited · Target Games Ltd · Thalassa Holdings (II) Ltd · Thalassa Holdings Ltd · WGP GEO Solutions Ltd
|
· Anemoi S.A. · Autonomous Robotics Limited · DOA Beta Ltd · DOA Gamma Ltd · Eastleigh Court Limited · Eastleigh Stables Limited · LML Acquisition Co plc · LML Acquisitions plc · Northward Holdings Ltd · NOS 7 Limited · Renewable Power & Light Ltd · Salattha Limited · Tappit Technologies (UK) Ltd. · WGP Group AT GmbH |
Roy and Andrew do not have an interest in the Company's ordinary shares. Duncan does not hold a direct interest in the Company, but Thalasaa Holdings Ltd is the Company's largest shareholder with an interest of 214,480,101 ordinary shares, representing 22.99% of the total voting rights (as at 12 September 2025).
There are no further disclosures to be made under Schedule Two Paragraph (g) of the AIM Rules for Companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site.
It is important for you to know that:
(a) none of the Content is, or is intended to be, general or personal advice
(b) the principal purpose of the Content is to provide factual information only and to comment on news;
(c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or investment strategy, and must not be relied upon by you as such;
(d) in providing you with the Content, we have not considered your objectives, financial situation or needs; and
(e) you should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
The Content contains data (including but not limited to prices, statistics and calculated information) obtained from a variety of third party sources (Third Party Data). The Company does not make any representation or warranty that any of the Content, including the Third Party Data, will be reliable, accurate or complete. The Company disclaims all responsibility and liability arising in any way from any errors or omissions in the Content, including the Third Party Data, including any loss you may incur in connection with any action or decision made by you in reliance upon the Content or Third Party Data.
In certain circumstances the Company, its related bodies corporate, or their affiliates, may have received, or be entitled to receive, financial or other consideration in connection with providing information about certain entities on the Site, which may include the above Content.
FOR OUR FULL DISCLAIMER CLICK HERE